Clinical Edge Journal Scan

Clinical Edge Journal Scan

HER2-positive breast cancer: Add-on trastuzumab lowers recurrence and mortality

• Read More

Clinical Edge Journal Scan

HR-positive breast cancer: Entinostat fails phase 3 trial

• Read More

Clinical Edge Journal Scan

Breast cancer: 10-year treatment extension with aromatase inhibitors yields no benefit

• Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Breast Cancer August 2021

Author:

Erin Roesch, MD

• Read More

Clinical Edge Journal Scan

Breast reconstruction: Chemotherapy does not increase complications and patient-reported outcomes

• Read More

Clinical Edge Journal Scan

HER2-positive breast cancer: Novel targeted therapies fall short in real-world setting

• Read More

Clinical Edge Journal Scan

Oligometastatic breast cancer: SABR extends long-term survival

• Read More

Clinical Edge Journal Scan

Denosumab improves bone-related outcomes in high-risk early-stage breast cancer

• Read More

Clinical Edge Journal Scan

Advanced breast cancer: Ribociclib maintains clinical benefit after dose reduction

• Read More

Clinical Edge Journal Scan

HER2-positive breast cancer: Trastuzumab biosimilar shows comparable long-term survival

• Read More